Dale Martin

The research in the Martin Lab focuses on identifying and characterising therapeutics that reduce levels of mutant huntingtin, the causative agent of the neurodegenerative disease Huntington disease (HD), by repairing the protein clearance pathway of autophagy and gene silencing. Our approach is highly collaborative and multi-faceted involving the identification of human SNPs, population genetics, protein characterization, chemical biology and high-resolution microscopy. Various aspects of these studies are performed in yeast, cell culture or mice.

• Bioinformatics, Systematics and Evolution
• Molecular Genetics
• Physiology, Cell and Developmental Biology
• Nanomaterials
• Biochemistry and Biophysics
• Drug Discovery, Design and Delivery
• Disease Detection and Modeling
• Neuroscience

• 2011 Ph.D. Cell Biology, University of Alberta, Canada
• 2003 B.Sc. Combined Honours in Biochemistry and Microbiology & Immunology, Dalhousie University, Canada

• Bluma Tischler Postdoctoral Fellowship, Faculty of Medicine – UBC
• Postdoctoral Fellowship, Michael Smith Foundation for Health Research (MSFHR)
• Postdoctoral Fellowship, Canadian Institutes for Health Research (CIHR)

• BIOL 302 - Functional Histology
  • Taught in 2020, 2021, 2022, 2023, 2024
• BIOL 472 - Cell Biology of Human Disease
  • Taught in 2021, 2022, 2023, 2024

* Only courses taught in the past 5 years are displayed.

• View Dale Martin's latest publications on his Google Scholar profile: https://scholar.google.ca/citations?hl=en&user=nQHYVhEAAAAJ&view_op=list_works&sortby=pubdate